Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer.

ABSTRACT: Immune checkpoints are unique components of the body's defense mechanism that safeguard the body from immune responses that are potent enough to harm healthy body cells. When proteins present on the surface of T cells recognize and bind to the proteins present on other tumor cells, immune checkpoints are triggered. These proteins are called immunological checkpoints. The T cells receive an on/off signal when the checkpoints interact with companion proteins. This might avert the host's immune system from eliminating cancer cells. The standard care plan for the treatment of non-small cell lung cancer (NSCLC) has been revolutionized with the use of drugs targeting immune checkpoints, in particular programmed cell death protein 1. These drugs are now extended for their potential to manage SCLC

SUBMITTER: Khadela A 

PROVIDER: S-EPMC9856297 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature